Metabolism of the neurotoxic amino acid β-N-methylamino-L-alanine in human cell culture models
Autor: | Simoné Downing, Gabré Kemp, T.G. Downing, Rianita van Onselen |
---|---|
Rok vydání: | 2019 |
Předmět: |
0106 biological sciences
Biological Availability Apoptosis Toxicology 01 natural sciences Necrosis 03 medical and health sciences Intestine Small Excitatory Amino Acid Agonists medicine Humans Neurotoxin Amino Acids Alanine chemistry.chemical_classification Proteinogenic amino acid 0303 health sciences Cyanobacteria Toxins 010604 marine biology & hydrobiology 030302 biochemistry & molecular biology Amino Acids Diamino Hep G2 Cells Metabolism Small intestine Amino acid Metabolic pathway medicine.anatomical_structure Liver chemistry Biochemistry Toxicity Caco-2 Cells |
Zdroj: | Toxicon. 168:131-139 |
ISSN: | 0041-0101 |
Popis: | Human dietary exposure to the environmental neurotoxin β-N-methylamino-L-alanine (BMAA) has been implicated in an increased risk of developing sporadic neurodegenerative diseases like Alzheimer's and amyotrophic lateral sclerosis. Evidence suggests that humans are exposed to BMAA globally, but very little is known about BMAA metabolism in mammalian systems, let alone in humans. The most plausible, evidence-based mechanisms of BMAA toxicity rely on the metabolic stability of the amino acid and that, following ingestion, it enters the circulatory system unmodified. BMAA crosses from the intestinal lumen into the circulatory system, and the small intestine and liver are the first sites for dietary amino acid metabolism. Both tissues have substantial amino acid metabolic needs, which are largely fulfilled by dietary amino acids. Metabolism of BMAA in these tissues has been largely overlooked, yet is important in gauging the true human exposure risk. Here we investigate the potential for BMAA metabolism by the human liver and small intestine, using in vitro cell systems. Data show that BMAA metabolism via common proteinogenic amino acid metabolic pathways is negligible, and that in the presence of other amino acids cellular uptake of BMAA is substantially reduced. These data suggest that the majority of ingested BMAA remains unmodified following passage through the small intestine and liver. This not only supports oral BMAA exposure as a plausible exposure route to toxic doses of BMAA, but also supports previous notions that protein deficient diets or malnutrition may increase an individual's susceptibility to BMAA absorption and subsequent toxicity. |
Databáze: | OpenAIRE |
Externí odkaz: |